Invesco Ltd. Cyclerion Therapeutics, Inc. Transaction History

Invesco Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.69 - $5.12 $93,022 - $177,054	-34,581 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.25 - $7.12 $3,496 - $11,064	1,554 Added 4.71%	34,581 $106,000
Q3 2020 Nov 16, 2020	SELL	$3.46 - $8.39 $3,370 - $8,171	-974 Reduced 2.86%	33,027 $201,000
Q2 2020 Aug 14, 2020	SELL	$2.37 - $7.14 $9,235 - $27,824	-3,897 Reduced 10.28%	34,001 $201,000
Q1 2020 May 15, 2020	BUY	$2.46 - $5.84 $93,229 - $221,324	37,898 New	37,898 $100,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $78.3M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.